Loading…

Activation of interleukin-32 pro-inflammatory pathway in response to influenza A virus infection

Interleukin (IL)-32 is a recently described pro-inflammatory cytokine that has been reported to be induced by bacteria treatment in culture cells. Little is known about IL-32 production by exogenous pathogens infection in human individuals. In this study, we found that IL-32 level was increased by 5...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2008-04, Vol.3 (4), p.e1985-e1985
Main Authors: Li, Wei, Liu, Yan, Mukhtar, Muhammad Mahmood, Gong, Rui, Pan, Ying, Rasool, Sahibzada T, Gao, Yecheng, Kang, Lei, Hao, Qian, Peng, Guiqing, Chen, Yanni, Chen, Xin, Wu, Jianguo, Zhu, Ying
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Interleukin (IL)-32 is a recently described pro-inflammatory cytokine that has been reported to be induced by bacteria treatment in culture cells. Little is known about IL-32 production by exogenous pathogens infection in human individuals. In this study, we found that IL-32 level was increased by 58.2% in the serum samples from a cohort of 108 patients infected by influenza A virus comparing to that of 115 healthy individuals. Another pro-inflammatory factor cyclooxygenase (COX)-2-associated prostaglandin E2 was also upregulated by 2.7-fold. Expression of IL-32 in influenza A virus infected A549 human lung epithelial cells was blocked by either selective COX-2 inhibitor NS398 or Aspirin, a known anti-inflammatory drug, indicating IL-32 was induced through COX-2 in the inflammatory cascade. Interestingly, we found that COX-2-associate PGE(2) production activated by influenza virus infection was significantly suppressed by over-expression of IL-32 but increased by IL-32-specific siRNA, suggesting there was a feedback mechanism between IL-32 and COX-2. IL-32 is induced by influenza A virus infection via COX-2 in the inflammatory cascade. Our results provide that IL-32 is a potential target for anti-inflammatory medicine screening.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0001985